Xenagos Bio, Inc. — Form D

Xenagos Bio, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-15. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-05-15
• Form: D
• Accession: 0002134608-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.5M
• Amount sold: $2.5M
• Investors: 23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-584166

Issuer

• Name: Xenagos Bio, Inc.
• CIK: 0002134608
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 121 S. BROAD ST., 15TH FLOOR, #1015, PHILADELPHIA, PA, 19107
• Phone: (610) 716-3542

Officers, directors & promoters (3)

More

• CIK 2134608 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search